Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-24-004310

President and CEO acquired 685,131 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gillheeney Gary S. President and CEO 2024-02-21 Grant or award +685,131 2,362,062 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gillheeney Gary S. President and CEO 2024-02-21 Grant or award · Stock Option (Right to Buy) +1,238,729 1,238,729 D: show line 2 in the form
Loading xslF345X05/form4.xml…